MoonLake Immunotherapeutics (MLTX) Earnings Date, Estimates & Call Transcripts $53.82 +0.71 (+1.34%) (As of 12:59 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 12EstimatedActual EPS (Aug. 7) -$0.39 Missed By -$0.11 Consensus EPS (Aug. 7) -$0.28 Conference Call TranscriptConference Call AudioEarnings Press ReleaseSEC 10-Q/10-K Filing Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMLTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MLTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election Meltdown” coming this November.Click here now to see Jim’s shocking predictions for November. MoonLake Immunotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.30)($0.20)($0.25)Q2 20243($0.38)($0.23)($0.29)Q3 20243($0.55)($0.39)($0.47)Q4 20243($0.66)($0.42)($0.53)FY 202411($1.89)($1.24)($1.53)Q1 20251($0.71)($0.71)($0.71)Q2 20251($0.78)($0.78)($0.78)Q3 20251($0.69)($0.69)($0.69)Q4 20251($0.63)($0.63)($0.63)FY 20254($2.81)($2.81)($2.81)MLTX Earnings Date and InformationMoonLake Immunotherapeutics last released its earnings results on August 7th, 2024. The reported ($0.39) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.28) by $0.11. MoonLake Immunotherapeutics has generated ($0.75) earnings per share over the last year (($0.75) diluted earnings per share). Earnings for MoonLake Immunotherapeutics are expected to decrease in the coming year, from ($1.45) to ($2.47) per share. MoonLake Immunotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off prior year's report dates.Read More MoonLake Immunotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/12/2024(Estimated)------- 8/7/2024Q2 2024($0.28)($0.39)($0.11)($0.39)-- 5/12/2024Q1 2024($0.19)($0.22)($0.03)($0.22)-- 2/29/2024Q4 2023($0.23)($0.12)+$0.11($0.12)-- 11/14/2023Q3 2023($0.23)($0.18)+$0.05($0.18)-- 8/10/2023Q2 2023($0.27)($0.23)+$0.04($0.23)-- 5/12/2023Q1 2023($0.28)($0.23)+$0.05($0.23)-- Kamala Harris and The Woke Progressive Nightmare (Ad)New research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election Meltdown” coming this November.Click here now to see Jim’s shocking predictions for November.3/20/2023Q4 2022($0.33)($0.31)+$0.02($0.31)-- 11/14/2022Q3 2022($0.32)($0.27)+$0.05($0.27)-- 8/12/2022Q2 2022-($0.34)($0.34)($0.34)--5/16/2022Q1 2022-($0.18)($0.18)($0.18)-- MoonLake Immunotherapeutics Earnings - Frequently Asked Questions When is MoonLake Immunotherapeutics's earnings date? MoonLake Immunotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on MLTX's earnings history. Did MoonLake Immunotherapeutics beat their earnings estimates last quarter? In the previous quarter, MoonLake Immunotherapeutics (NASDAQ:MLTX) missed the analysts' consensus estimate of ($0.28) by $0.11 with a reported earnings per share (EPS) of ($0.39). Learn more on analysts' earnings estimate vs. MLTX's actual earnings. How can I listen to MoonLake Immunotherapeutics's earnings conference call? The conference call for MoonLake Immunotherapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read MoonLake Immunotherapeutics's conference call transcript? The conference call transcript for MoonLake Immunotherapeutics's latest earnings report can be read online. Read Transcript How can I view MoonLake Immunotherapeutics's earnings report? MoonLake Immunotherapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much profit does MoonLake Immunotherapeutics generate each year? MoonLake Immunotherapeutics (NASDAQ:MLTX) has a recorded net income of -$36.01 million. MLTX has generated -$0.75 earnings per share over the last four quarters. What is MoonLake Immunotherapeutics's EPS forecast for next year? MoonLake Immunotherapeutics's earnings are expected to decrease from ($1.45) per share to ($2.47) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Cipher Mining Earnings DocGo Earnings Quantum-Si Earnings Cherry Hill Mortgage Investment Earnings Vincerx Pharma Earnings Cerevel Therapeutics Earnings Sarepta Therapeutics Earnings Catalent Earnings Qiagen Earnings Legend Biotech Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:MLTX) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding MoonLake Immunotherapeutics You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share MoonLake Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLTX Stock Alerts